4Filing Date: Sep 9, 2026

RxSight (RXST)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001193125-26-386838
Total Value$0
Trades8
Insiders1

Transaction Details

Kurtz Ronald M MD
Chief Medical Officer·Direct
Dispose · Dispose
Stock Option (right to buy)Derivative
Shares-149.00K
Price-
Total Value$0
Shares Owned After0
Transaction DateSep 5, 2026
Exercise Price$56.07
ExpiresMar 3, 2034
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Grant · Acquire
Stock Option (right to buy)Derivative
Shares+96.13K
Price-
Total Value$0
Shares Owned After96.13K
Transaction DateSep 5, 2026
Exercise Price$6.38
ExpiresSep 4, 2033
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,080 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,080 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 36,049 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Dispose · Dispose
Stock Option (right to buy)Derivative
Shares-200.00K
Price-
Total Value$0
Shares Owned After0
Transaction DateSep 5, 2026
Exercise Price$14.95
ExpiresMar 8, 2033
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Grant · Acquire
Stock Option (right to buy)Derivative
Shares+254.75K
Price-
Total Value$0
Shares Owned After254.75K
Transaction DateSep 5, 2026
Exercise Price$6.38
ExpiresSep 4, 2033
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Dispose · Dispose
Stock Option (right to buy)Derivative
Shares-215.00K
Price-
Total Value$0
Shares Owned After0
Transaction DateSep 5, 2026
Exercise Price$28.21
ExpiresFeb 26, 2035
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Grant · Acquire
Stock Option (right to buy)Derivative
Shares+161.65K
Price-
Total Value$0
Shares Owned After161.65K
Transaction DateSep 5, 2026
Exercise Price$6.38
ExpiresSep 4, 2033
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,620 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,620 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 101,034 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Dispose · Dispose
Stock option (right to buy)Derivative
Shares-338.82K
Price-
Total Value$0
Shares Owned After0
Transaction DateSep 5, 2026
Exercise Price$16.00
ExpiresJul 30, 2031
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share.

Kurtz Ronald M MD
Chief Medical Officer·Direct
Grant · Acquire
Stock Option (right to buy)Derivative
Shares+173.91K
Price-
Total Value$0
Shares Owned After173.91K
Transaction DateSep 5, 2026
Exercise Price$6.38
ExpiresSep 4, 2033
Footnotes ▸

On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. | Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 148,549 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 148,549 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 25,364 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter.

Post-Transaction Holdings

Kurtz Ronald M MD · Chief Medical Officer
SecuritySharesChange
Stock option (right to buy)0-338.82K (-100.00%)
Stock Option (right to buy)0+122.45K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-05 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: RxSight, Inc. (RXST) CIK: 0001111485 --- Reporting Owner --- Name: Kurtz Ronald M MD CIK: 0001295469 Role: Officer (Chief Medical Officer) --- Derivative Transactions --- [Transaction #1] Security: Stock option (right to buy) Date: 2026-09-05 | Code: D (Sale to issuer) Shares: -338,819 Exercise Price: $16.00 Exercisable: N/A | Expires: 2031-07-30 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. [Transaction #2] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: D (Sale to issuer) Shares: -200,000 Exercise Price: $14.95 Exercisable: N/A | Expires: 2033-03-08 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F3] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. [F2] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. [Transaction #3] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: D (Sale to issuer) Shares: -149,000 Exercise Price: $56.07 Exercisable: N/A | Expires: 2034-03-03 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F5] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. [F4] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. [Transaction #4] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: D (Sale to issuer) Shares: -215,000 Exercise Price: $28.21 Exercisable: N/A | Expires: 2035-02-26 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. [F6] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. [Transaction #5] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: A (Grant or award) Shares: +254,751 Exercise Price: $6.38 Exercisable: N/A | Expires: 2033-09-04 Shares Owned After: 254,751 | Ownership: D (Direct) Footnotes: [F1] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. [F7] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. [Transaction #6] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: A (Grant or award) Shares: +173,913 Exercise Price: $6.38 Exercisable: N/A | Expires: 2033-09-04 Shares Owned After: 173,913 | Ownership: D (Direct) Footnotes: [F3] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. [F8] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 148,549 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 148,549 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 25,364 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. [Transaction #7] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: A (Grant or award) Shares: +96,129 Exercise Price: $6.38 Exercisable: N/A | Expires: 2033-09-04 Shares Owned After: 96,129 | Ownership: D (Direct) Footnotes: [F5] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. [F9] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,080 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,080 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 36,049 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. [Transaction #8] Security: Stock Option (right to buy) Date: 2026-09-05 | Code: A (Grant or award) Shares: +161,654 Exercise Price: $6.38 Exercisable: N/A | Expires: 2033-09-04 Shares Owned After: 161,654 | Ownership: D (Direct) Footnotes: [F1] On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. [F10] Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,620 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,620 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 101,034 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. --- Footnotes (Complete Index) --- F1: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F10: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,620 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,620 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 101,034 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. F2: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. F3: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. F4: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. F5: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F6: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. F7: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. F8: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 148,549 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 148,549 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 25,364 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. F9: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 60,080 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 60,080 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 36,049 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. --- Signature --- /s/ /s/ Jim Schindler, as Attorney-in-Fact (2026-09-09)

keid analysis is for reference only and does not constitute investment advice.